<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01144520</url>
  </required_header>
  <id_info>
    <org_study_id>2009H0270</org_study_id>
    <nct_id>NCT01144520</nct_id>
  </id_info>
  <brief_title>Leukocyte Dysfunction in Diabetic Patients.</brief_title>
  <official_title>Leukocyte Dysfunction in Diabetic Patients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sashwati Roy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ohio State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to study impairment of white blood cell function in patients
      with type II diabetes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Leucocytes from poorly controlled diabetes exhibit aberrant chemotaxis, increased
      susceptibility to bacterial infection, leukotriene production, lysosomal enzyme release,
      proinflammatory cytokine expression and production of reactive oxygen species. Aberrant
      glucose concentration in diabetics affects functions of peripheral blood system as well as
      the immune system leading to impaired host defense. Impaired wound healing is a serious
      complication associated with diabetes. We hypothesized that impairment in leukocyte function
      results in dysfunctional inflammatory response in diabetic wounds. The proposed studies focus
      on characterizing mechanisms that will improve our understanding of the dysfunctional
      inflammatory response resulting in non-healing chronic wounds in diabetics.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>March 2010</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Ex vivo leukocyte function by measuring ROS production</measure>
    <time_frame>immediately after blood draw</time_frame>
    <description>After blood draw monocytes are separated from whole blood and production of oxidants by these cells</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ex vivo NADPH oxidase gene and protein expression</measure>
    <time_frame>After blood draw</time_frame>
    <description>Gene and protein expressions are measured using Western blot and real time PCR.</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>Normoglycemic</arm_group_label>
    <description>Healthy subjects that do not have diabetes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Type II Diabetes (HbA1c &lt;7 or 7%)</arm_group_label>
    <description>Subject that have Type II Diabetes with good glucose control with glycated hemoglobin (HbA1c &lt;7 or 7%)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Type II Diabetes (HbA1c between 7.1-9)</arm_group_label>
    <description>Subjects with Type II Diabetes with moderate glucose control (HbA1c between 7.1-9)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Type II Diabetes (HbA1c &gt;9%)</arm_group_label>
    <description>Subjects with Type II Diabetes with poor glucose control (HbA1c &gt;9%)</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects will be recruited from the population who visit the Ohio State University (OSU)
        Hospitals and Comprehensive Wound Center (CWC), OSU Wexner Medical Center diabetic clinics
        and Bariatric clinic.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults ages 40-60 yrs old clinically diagnosed with Type II Diabetes

          -  Adults ages 40-60 yrs old without Diabetes

        Exclusion Criteria:

          -  Unable to provide informed consent

          -  Pregnant Females

          -  Therapeutically Immuno-compromised
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roy Sashwati, MS, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ohio State University Dept of Surgery</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ohio State University Comprehensive Wound Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43221</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://medicine.osu.edu/regenerativemedicine/Pages/index.aspx</url>
    <description>OSU Center for Regenerative Medicine and Cell Based Therapies</description>
  </link>
  <link>
    <url>http://medicalcenter.osu.edu/patientcare/healthcare_services/wound_care/Pages/index.aspx</url>
    <description>OSU Comprehensive Wound Center</description>
  </link>
  <results_reference>
    <citation>Shurtz-Swirski R, Sela S, Herskovits AT, Shasha SM, Shapiro G, Nasser L, Kristal B. Involvement of peripheral polymorphonuclear leukocytes in oxidative stress and inflammation in type 2 diabetic patients. Diabetes Care. 2001 Jan;24(1):104-10.</citation>
    <PMID>11194213</PMID>
  </results_reference>
  <results_reference>
    <citation>Lin X, Candlish JK, Thai AC. Superoxide production by neutrophils from diabetics and normal subjects in response to glucose and galactose. Exp Mol Pathol. 1993 Jun;58(3):229-36.</citation>
    <PMID>8390941</PMID>
  </results_reference>
  <results_reference>
    <citation>Molenaar DM, Palumbo PJ, Wilson WR, Ritts RE Jr. Leukocyte chemotaxis in diabetic patients and their nondiabetic first-degree relatives. Diabetes. 1976;25(2 SUPPL):880-3.</citation>
    <PMID>971792</PMID>
  </results_reference>
  <results_reference>
    <citation>Hill HR, Sauls HS, Dettloff JL, Quie PG. Impaired leukotactic responsiveness in patients with juvenile diabetes mellitus. Clin Immunol Immunopathol. 1974 Apr;2(3):395-403.</citation>
    <PMID>4826528</PMID>
  </results_reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 14, 2010</study_first_submitted>
  <study_first_submitted_qc>June 14, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 15, 2010</study_first_posted>
  <last_update_submitted>March 16, 2018</last_update_submitted>
  <last_update_submitted_qc>March 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Ohio State University</investigator_affiliation>
    <investigator_full_name>Sashwati Roy</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

